Full name
GRUPA CBD SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.99.Z - Other retail sale not in stores, stalls or markets
01.1 - Growing of non-perennial crops
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.19.Z - Agents involved in the sale of a variety of goods
47.7 - Retail sale of other goods in specialised stores
71.20 - Technical testing and analysis
72.1 - Research and experimental development on natural sciences and engineering
85.59 - Other education n.e.c.
86.90 - Other human health activities
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 2,8 | -25,7 | -10,9 | 57,4 |
EBITDA | 2,8 | -25,7 | -10,9 | 57,4 |
Short time liabilities | 577,4 | 787,9 | 543,4 | -31 |
Equity capital | -429,1 | -454,8 | -465,4 | -2,3 |
Operating profit (EBIT) | 2,8 | -25,7 | -10,9 | 57,4 |
Assets | 148,3 | 333,5 | 78 | -76,6 |
Net profit (loss) | 2,8 | -25,7 | -10,9 | 57,4 |
Cash | 7,1 | 0,3 | 0,7 | 105,4 |
Net income from sale | 15 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 577,4 | 788,3 | 543,4 | -31,1 |
Working assets | 147,8 | 101,1 | 77,5 | -23,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -0,7 | 5,6 | 2,4 | -3,2 |
Equity capital to total assets | -289,4 | -136,4 | -596,4 | -460 |
Gross profit margin | 19 | 88,8 | ||
EBITDA Margin | 19 | 88,8 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 049 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.2559545040130615 | 0.12826214730739594 | 0.14268122613430023 | 0 |
Net dept to EBITDA | 200.0635986328125 | -20.079748153686523 | -48.61649703979492 | -28,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane